Search Videos and More
Video
About the Advanced Endoscopy Fellowship | Cedars-Sinai Academic Medicine
Cedars-Sinai is an intense, one-year program that provides a comprehensive learning experience. It covers the full spectrum of clinical and cognitive activities in a full-time, academic interventional gastroenterology practice.
Video
About the Abdominal Transplant Surgery Fellowship | Cedars-Sinai Academic Medicine
The Cedars-Sinai Abdominal Transplant Surgery Fellowship is an American Society of Transplant Surgeons (ASTS)-accredited program offering comprehensive surgical training in liver, kidney and pancreas transplantation and hepatopancreaticobiliary (HPB) surgery.
News
Protein Found to Indicate GI Tumors
Claudin-18 is expressed in some gastric cancers. Clinical trials are evaluating it as a therapeutic target.
News
New Method Detects Gut Microbes That Activate Immune Cells
Ivan Vujkovic-Cvijin, PhD, an assistant professor in the Department of Biomedical Sciences and Gastroenterology, helped develop a new technique that detects the gut microbes that have crossed the gut barrier and activated immune cells throughout the body.
Podcast
Bringing Virtual Reality to Clinical Spaces with Dr. Brennan Spiegel
Brennan Spiegel, MD, MSHS, director of health services research, is interested in the way the brain and gut communicate specifically in cases of IBS, and how virtual reality (VR) can help change a patient's perceptions of pain that are often amplified by fear and anxiety.
News
How IBD Patients Respond to COVID-19 Vaccines
Patients with inflammatory bowel disease (IBD) who received the COVID-19 vaccine from Johnson & Johnson produced significantly lower levels of antibodies against the SARS-CoV-2 virus than those who received the Pfizer-BioNTech or Moderna vaccines, according to a study led by Cedars-Sinai.
News
Landmark IBD study in African Americans
In African Americans, the genetic risk landscape for inflammatory bowel disease (IBD) is very different from that of people with European ancestry, according to the first whole-genome study of IBD in African Americans. The authors say that future clinical research on IBD needs to take ancestry into account.
News
Compound Tested for Alcoholic Liver Disease
Alcohol-associated liver disease (ALD) is a leading cause of death and severe illness. More than 95,000 people die in the U.S each year from excessive alcohol use, according to the federal Centers for Disease Control and Prevention.
Podcast
Pioneers in Medicine with Dr. Gewertz: Making Personalized Medicine Possible for IBD Patients
In this episode of “Pioneers in Medicine,” Stephan Targan, MD, explains the recent shift to more aggressive treatment plans and how new therapies promote precision medicine, driving positive outcomes for each unique individual.
News
COVID-19: Enzyme Targeted by Virus Also Influences Gut Inflammation
Cedars-Sinai Study Suggests ACE2, Which Helps Coronavirus Invade Cells, May Be a Double-Edged Sword">The novel coronavirus as seen under a microscope. Courtesy of the National Institutes of Health.
News
Easy to Digest
Study of the microbiome—the trillions of bacteria living in and on our bodies—traditionally focuses on the colon, the biggest part of the large intestine. Stool has been the star, so far, when it comes to understanding how colonies of tiny organisms play a part in our health.
News
Cedars-Sinai Receives $25M to Create Karsh GI and Hepatology Division
A $25 million gift from Martha L. Karsh, Bruce A. Karsh and the Karsh Family Foundation will support innovative research and treatment of digestive and liver diseases.
BROADCASTMED